Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations

aDepartment of Investigational Cancer Therapeutics, Division of Cancer Medicine

bDepartment of Gynecologic Oncology and Reproductive Medicine, Division of Surgery

cThe Institute for Applied Cancer Science

dKhalifa Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Correspondence to Timothy A. Yap, MBBS, PhD, FRCP, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA. Tel: +1 713 563 1784; e-mail: [email protected]

留言 (0)

沒有登入
gif